RNAa Induced by TATA Box-Targeting MicroRNAs

Area of Science:

• Molecular Biology
• Epigenetics
• Virology

Background:

• Recent research shows small RNAs can activate gene transcription via RNA activation (RNAa).
• Nuclear microRNAs (miRNAs) and synthesized small interfering RNAs (siRNAs) have been implicated in targeting gene promoters.
• The precise mechanisms and applications of RNAa are areas of active investigation.

Purpose of the Study:

• To identify and characterize novel miRNAs involved in RNA activation.
• To investigate the role of a specific HIV-1 encoded miRNA, miR-H3, in viral gene expression.
• To explore the potential of TATA box-targeting small RNAs for therapeutic applications, including HIV-1 latency.

Main Methods:

• Identification of HIV-1 encoded miRNA, miR-H3.
• Assessing the impact of miR-H3 depletion and mimics on HIV-1 replication in CD4+ T cells.
• Investigating the function of cellular miRNAs, such as let-7i, in targeting promoter TATA boxes.
• Analyzing the requirement of Argonaute (AGO) proteins in TATA box-mediated RNAa.
• Testing synthesized small RNAs for their ability to activate transcription of target genes (insulin, IL-2, c-Myc).

Main Results:

• A novel HIV-1 miRNA, miR-H3, was identified, targeting the HIV-1 promoter TATA box to activate viral gene expression.
• Depletion of miR-H3 significantly inhibited HIV-1 replication.
• miR-H3 mimics activated HIV-1 in CD4+ T cells from patients on suppressive therapy, suggesting a role in reducing latent reservoirs.
• Cellular miRNAs, like let-7i, were found to target TATA boxes and upregulate gene expression (e.g., IL-2).
• RNA activation by TATA box-targeting miRNAs requires AGO proteins but not promoter-associated transcripts or epigenetic modifications.
• Synthesized small RNAs targeting TATA boxes efficiently activated transcription of genes like insulin, IL-2, and c-Myc.

Conclusions:

• TATA box-targeting miRNAs, including viral and cellular miRNAs, represent a novel mechanism for RNA activation (RNAa).
• This discovery provides a facile method for activating gene expression, with potential applications in managing viral infections and other diseases.
• The ability of miR-H3 mimics to reactivate latent HIV-1 offers a promising avenue for developing new therapeutic strategies against HIV-1 latency.